Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial-Reference-Cited by-同舟云学术

Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial

Published:2020-12 Issue:12 Volume:2 Page:e764-e773
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Vlaar Alexander P J,de Bruin Sanne,Busch Matthias,Timmermans Sjoerd A M E G,van Zeggeren Ingeborg E,Koning Rutger,ter Horst Liora,Bulle Esther B,van Baarle Frank E H P,van de Poll Marcel C G,Kemper E Marleen,van der Horst Iwan C C,Schultz Marcus J,Horn Janneke,Paulus Frederique,Bos Lieuwe D,Wiersinga W Joost,Witzenrath Martin,Rueckinger Simon,Pilz Korinna,Brouwer Matthijs C,Guo Ren-Feng,Heunks Leo,van Paassen Pieter,Riedemann Niels C,van de Beek Diederik

Funder

German Research Foundation

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference28 articles.

1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

2. Clinical characteristics of coronavirus disease 2019 in China;Guan;N Engl J Med,2020

3. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy;Grasselli;JAMA,2020

4. The trinity of COVID-19: immunity, inflammation and intervention;Tay;Nat Rev Immunol,2020

5. SARS-CoV-2 and viral sepsis: observations and hypotheses;Li;Lancet,2020

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the Evolving Pathophysiology of Coronavirus Disease 2019 and Adult Nursing Management;Critical Care Nursing Clinics of North America;2024-09

2. Cerebrovascular Complications in Bacterial Meningitis;Stroke: Vascular and Interventional Neurology;2024-08-26

3. Challenges of consolidating evidence collected during a pandemic and lessons for the future;Current Medical Research and Opinion;2024-07-23

4. Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information;Medical Decision Making;2024-06-03

5. The effect of immunosuppressive therapies on the endothelial host response in critically ill COVID-19 patients;Scientific Reports;2024-04-20